anti-GAD65 autoantibody

Also Known As:

Anti-glutamic acid decarboxylase 65 autoantibody; GAD65 autoantibody; anti-glutamate decarboxylase 2 autoantibody

Networked: 25 relevant articles (0 outcomes, 1 trials/studies)

Bio-Agent Context: Research Results

Amino Acids, Peptides, and Proteins: 1
- Proteins: 484843
  - Blood Proteins: 12459
    - Serum Globulins: 553
      - Immunoglobulins: 30480
        Antibodies: 133716
        Autoantibodies: 35785
        anti-GAD65 autoantibody: 25
    - Immunoproteins: 43
      - Immunoglobulins: 30480
        Antibodies: 133716
        Autoantibodies: 35785
        anti-GAD65 autoantibody: 25
  - Globulins: 3062
    - Serum Globulins: 553
      - Immunoglobulins: 30480
        Antibodies: 133716
        Autoantibodies: 35785
        anti-GAD65 autoantibody: 25

Experts

1.	Hampe, Christiane S: 4 articles (10/2018 - 02/2002)
2.	Lernmark, A: 4 articles (05/2007 - 12/2000)
3.	Cilio, C M: 3 articles (07/2011 - 12/2006)
4.	Hampe, C S: 3 articles (05/2007 - 12/2000)
5.	Akesson, C: 2 articles (07/2011 - 12/2006)
6.	Arvastsson, J: 2 articles (07/2011 - 12/2006)
7.	Svensson, J: 2 articles (07/2011 - 12/2006)
8.	Bekris, L M: 2 articles (05/2007 - 04/2007)
9.	Bahnson, Henry T: 1 article (01/2022)
10.	Bruggeman, Brittany S: 1 article (01/2022)

Related Diseases

1.	Type 1 Diabetes Mellitus (Autoimmune Diabetes) 01/01/2023 - "Anti-GAD65 autoantibody levels measured by ELISA and alternative types of immunoassays in relation to neuropsychiatric diseases versus diabetes mellitus type 1." 01/01/2014 - "CD226 rs763361 is associated with the susceptibility to type 1 diabetes and greater frequency of GAD65 autoantibody in a Brazilian cohort." 01/01/2012 - "Anti-idiotypic antibody specific to GAD65 autoantibody prevents type 1 diabetes in the NOD mouse." 08/01/2008 - "GAD65 autoantibody responses in Japanese latent autoimmune diabetes in adult patients." 04/01/2006 - "Mean recovery of GAD65 from the plasma of control subjects and GAD65 autoantibody-positive and -negative subjects with type 1 diabetes was 101 +/- 4.6%, 88 +/- 7.8%, and 99 +/- 7.0% (+/- SEM), respectively. "
2.	Thyroid Diseases (Thyroid Disease) 07/01/2011 - "Several studies indicate that in utero exposure to maternal autoimmune diseases and transplacental passage of autoantibodies affect the risk of autoimmunity in the offspring, e. g., maternally derived GAD65 autoantibody correlates with decreased risk of type 1 diabetes, whereas thyroid peroxidase autoantibody (TPOAb) positivity at birth is associated with increased incidence of autoimmune thyroid disease later in life. "
3.	Autoimmune Diseases (Autoimmune Disease) 07/01/2011 - "Several studies indicate that in utero exposure to maternal autoimmune diseases and transplacental passage of autoantibodies affect the risk of autoimmunity in the offspring, e. g., maternally derived GAD65 autoantibody correlates with decreased risk of type 1 diabetes, whereas thyroid peroxidase autoantibody (TPOAb) positivity at birth is associated with increased incidence of autoimmune thyroid disease later in life. "
4.	Epilepsy (Aura) 10/01/2018 - "GAD65 autoantibody characteristics in patients with co-occurring type 1 diabetes and epilepsy may help identify underlying epilepsy etiologies." 12/01/2016 - "Seizure control and cognitive improvement via immunotherapy in late onset epilepsy patients with paraneoplastic versus GAD65 autoantibody-associated limbic encephalitis."
5.	Limbic Encephalitis (Paraneoplastic Limbic Encephalitis) 12/01/2016 - "Seizure control and cognitive improvement via immunotherapy in late onset epilepsy patients with paraneoplastic versus GAD65 autoantibody-associated limbic encephalitis."

Related Drugs and Biologics

1.	Autoantibodies
2.	Iodide Peroxidase (Deiodinase)
3.	Glutamate Decarboxylase (Decarboxylase, Glutamate)
4.	Epitopes
5.	HLA-DR Antigens (HLA-DR)
6.	Class 8 Receptor-Like Protein Tyrosine Phosphatases
7.	Calcitriol Receptors (Calcitriol Receptor)
8.	Protein Tyrosine Phosphatases
9.	Interleukin-8 (Interleukin 8)
10.	HLA-DR3 Antigen (HLA DR3 Antigen)

Related Therapies and Procedures

1.	Therapeutics
2.	Immunotherapy